{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:33:11Z","timestamp":1759177991106},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s11938-005-0035-7","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T17:45:28Z","timestamp":1180892728000},"page":"481-492","source":"Crossref","is-referenced-by-count":2,"title":["Autoimmune hepatitis"],"prefix":"10.1007","volume":"8","author":[{"given":"Joseph","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"35_CR1","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PJ Johnson","year":"1993","unstructured":"Johnson PJ, McFarlane IG: Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993, 18: 998\u20131005.","journal-title":"Hepatology"},{"key":"35_CR2","first-page":"181","volume":"90","author":"J Ludwig","year":"1995","unstructured":"Ludwig J, McFarlane IG, Rakela J: International Working Party Report: Terminology of chronic hepatitis. Am J Gastro 1995, 90: 181\u2013189.","journal-title":"Am J Gastro"},{"key":"35_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK: AASLD Practice Guidelines-Diagnosis and treatment of autoimmune hepatitis. Hepatology, 2002, 36: 479\u2013497. Practice guidelines that summarize recommendations.","journal-title":"Hepatology"},{"key":"35_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.2003.01389.x","volume":"17","author":"J Medina","year":"2003","unstructured":"Medina J, Garcia-Buey L, Moreno-Otero R: Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis. Aliment Pharmacol Ther, 2003, 17: 1\u201316.","journal-title":"Aliment Pharmacol Ther"},{"key":"35_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","volume":"33","author":"KM Boberg","year":"1998","unstructured":"Boberg KM, Aadland E, Jahnsen J, et al.: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastro 1998, 33: 99\u2013103.","journal-title":"Scand J Gastro"},{"key":"35_CR6","first-page":"413","volume-title":"Geographical variation in the frequency and characteristics of autoimmune liver disease, in Autoimmune liver diseases, W.R.","author":"M Nishioka","year":"1998","unstructured":"Nishioka M, Morshed SA, McFarlane IG: Geographical variation in the frequency and characteristics of autoimmune liver disease, in Autoimmune liver diseases, W.R. Krawitt EL, Nishioka M, Editor. Elsevier: Amsterdam. 1998, 413\u2013424."},{"key":"35_CR7","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/j.1572-0241.2001.05272.x","volume":"96","author":"KN Lim","year":"2001","unstructured":"Lim KN, Casanova RL, Boyer TD, et al.: Autoimmune hepatitis in African Americans: presenting features and response to therapy. Am J Gastro 2001, 96: 3390\u20133394.","journal-title":"Am J Gastro"},{"key":"35_CR8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/BF01076196","volume":"22","author":"SW Schalm","year":"1977","unstructured":"Schalm SW, Korman MG, Summerskill WH, et al.: Severe chronic active liver disease. Prognostic significance of initial morphologic patterns. Am J Dig Dis 1977, 22: 973\u2013980.","journal-title":"Am J Dig Dis"},{"key":"35_CR9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0016-5085(83)90030-6","volume":"85","author":"AJ Czaja","year":"1983","unstructured":"Czaja AJ, Davis GL, Ludwig J, et al.: Autoimmune features as determinants of prognosis in steroidtreated chronic active hepatitis of uncertain etiology. Gastroenterology 1983, 85: 713\u2013717.","journal-title":"Gastroenterology"},{"key":"35_CR10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.1840040409","volume":"4","author":"AJ Czaja","year":"1984","unstructured":"Czaja AJ, Davis GL, Ludwig J, Taswell HF: Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology 1984, 4: 622\u2013627.","journal-title":"Hepatology"},{"key":"35_CR11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al.: International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31: 929\u2013938.","journal-title":"J Hepatol"},{"key":"35_CR12","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","volume":"110","author":"SK Roberts","year":"1996","unstructured":"Roberts SK, Therneau T, Czaja AJ: Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996, 110: 848\u2013857.","journal-title":"Gastroenterology"},{"key":"35_CR13","first-page":"17","volume-title":"Clinical Transplants 1998","author":"EC Seaberg","year":"1999","unstructured":"Seaberg EC, Belle SH, Beringer KC, et al.: Liver transplantation in the United States from 1987\u20131998: updated results from the Pitt-UNOS liver transplant registry. In Clinical Transplants 1998. Edited by Cecka JM. Los Angeles: UCLA Tissue Typing Laboratories; 1999: 17\u201337."},{"key":"35_CR14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.20539","volume":"41","author":"AJ Czaja","year":"2005","unstructured":"CzajaAJ, Francesco BB, Carpenter HA, et al.: Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 2005, 41: 207\u2013215. Expert review of current investigational challenges in autoimmune hepatitis.","journal-title":"Hepatology"},{"key":"35_CR15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0016-5085(81)90126-8","volume":"80","author":"AJ Czaja","year":"1981","unstructured":"Czaja AJ, Wolf AM, Baggenstoss AH: Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features. Gastroenterology 1981, 80: 687\u2013692.","journal-title":"Gastroenterology"},{"key":"35_CR16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","volume":"63","author":"RD Soloway","year":"1972","unstructured":"Soloway RD, Summerskill WHJ, Baggenstoss AH, et al.: Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972, 63: 820\u2013833.","journal-title":"Gastroenterology"},{"key":"35_CR17","first-page":"221","volume":"8","author":"SW Schalm","year":"1976","unstructured":"Schalm SW, Ammon HV, Summerskill WH: Failure of customary treatment in chronic active liver disease: causes and management. Ann Clin Res 1976, 8: 221\u2013227.","journal-title":"Ann Clin Res"},{"key":"35_CR18","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/jhep.2002.32485","volume":"35","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Menon KV, Carpenter HA: Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Hepatology 2002, 35: 890\u2013897.","journal-title":"Hepatology"},{"key":"35_CR19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/lt.500040313","volume":"4","author":"M Hayash","year":"1998","unstructured":"Hayash M, Keeffe EB, Krams SM, et al.: Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg 1998, 4: 208\u2013214.","journal-title":"Liver Transpl Surg"},{"key":"35_CR20","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","volume":"44","author":"American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis","year":"2001","unstructured":"American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis: Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 2001, 44: 1496\u20131503.","journal-title":"Arthritis Rheum"},{"key":"35_CR21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.1840110621","volume":"11","author":"AJ Czaja","year":"1990","unstructured":"Czaja AJ: Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis. Hepatology 1990, 11: 1044\u20131049.","journal-title":"Hepatology"},{"key":"35_CR22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","volume":"16","author":"WHJ Summerskill","year":"1975","unstructured":"Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH: Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 1975, 16: 876\u2013883.","journal-title":"Gut"},{"key":"35_CR23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(94)92150-4","volume":"343","author":"WR Connell","year":"1994","unstructured":"Connell WR: Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994, 343: 1249\u20131252.","journal-title":"Lancet"},{"key":"35_CR24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/lt.500010305","volume":"1","author":"J Devlin","year":"1995","unstructured":"Devlin J, Donaldson P, Portmann B: Recurrence of autoimmune hepatitis following liver transplantation. Liver Transpl Surg 1995, 1: 162\u2013165.","journal-title":"Liver Transpl Surg"},{"key":"35_CR25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0041-1345(98)01692-3","volume":"31","author":"G Gotz","year":"1999","unstructured":"Gotz G, Neuhaus R, Bechstein WO, et al.: Recurrence of autoimmune hepatitis after liver transplantation. Transplant Proc 1999, 31: 430\u2013431.","journal-title":"Transplant Proc"},{"key":"35_CR26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","volume":"68","author":"P Milkiewicz","year":"1999","unstructured":"Milkiewicz P, Hubscher SG, Skiba G, et al.: Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999, 68: 253\u2013256.","journal-title":"Transplantation"},{"key":"35_CR27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","volume":"30","author":"V Ratziu","year":"1999","unstructured":"Ratziu V, Samuel D, Sebagh M, et al.: Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol 1999, 30: 131\u2013141.","journal-title":"J Hepatol"},{"key":"35_CR28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","volume":"7","author":"A Gonzalez-Koch","year":"2001","unstructured":"Gonzalez-Koch A, Czaja AJ, Carpenter HA, et al.: Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 2001, 7: 302\u2013310.","journal-title":"Liver Transpl"},{"key":"35_CR29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","volume":"33","author":"PD Richardson","year":"2000","unstructured":"Richardson PD, James PD, Ryder SD: Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol 2000, 33: 371\u2013375.","journal-title":"J Hepatol"},{"key":"35_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2004\/504591","volume":"18","author":"SM Devlin","year":"2004","unstructured":"Devlin SM, Swain MG, Urbanski SJ, Burak KW: Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy. Can J Gastroenterol, 2004, 18: 321\u2013326.","journal-title":"Can J Gastroenterol"},{"key":"35_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.1999.00807.x","volume":"94","author":"NF Fernandes","year":"1999","unstructured":"Fernandes NF, Redeker AG, Vierling JM, et al.: Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. Am J Gastro 1999, 94: 241\u2013248.","journal-title":"Am J Gastro"},{"key":"35_CR32","first-page":"771","volume":"90","author":"DH Thiel Van","year":"1995","unstructured":"Van Thiel DH, Wright H, Carroll P, et al.: Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastro 1995, 90: 771\u2013776.","journal-title":"Am J Gastro"},{"key":"35_CR33","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.mcg.0000139050.67178.be","volume":"38","author":"BA Aqel","year":"2004","unstructured":"Aqel BA, Machicao V, Rosser B, et al.: Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. J Clin Gastroenterol 2004, 38: 805\u2013809.","journal-title":"J Clin Gastroenterol"},{"key":"35_CR34","first-page":"A61","volume":"44","author":"MA Heneghan","year":"1999","unstructured":"Heneghan MA, Rizzi P, McFarlane IG, et al.: Low dose tacrolimus as treatment of severe autoimmune hepatitis: potential role in remission induction. Gut 1999, 44: A61.","journal-title":"Gut"},{"key":"35_CR35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.1994.tb00334.x","volume":"8","author":"A Danielsson","year":"1994","unstructured":"Danielsson A, Prytz H: Oral budesonide for treatment of autoimmune chronic active hepatitis. Aliment Pharmacol Ther 1994, 8: 585\u2013590.","journal-title":"Aliment Pharmacol Ther"},{"key":"35_CR36","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/gast.2000.0010000001","volume":"119","author":"AJ Czaja","year":"2000","unstructured":"Czaja AJ, Lindor KD: Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. Gastroenterology 2000, 119: 1312\u20131316.","journal-title":"Gastroenterology"},{"key":"35_CR37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1440-1746.1998.tb00674.x","volume":"13","author":"K Nakamura","year":"1998","unstructured":"Nakamura K, Yoneda M, Yokohama S, et al.: Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol 1998, 13: 490\u2013495.","journal-title":"J Gastroenterol Hepatol"},{"key":"35_CR38","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.510300603","volume":"30","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ, Carpenter HA, Lindor KD: Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial. Hepatology 1999, 30: 1381\u20131386.","journal-title":"Hepatology"},{"key":"35_CR39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/gast.1996.v110.pm8536867","volume":"110","author":"DS Pratt","year":"1996","unstructured":"Pratt DS, Flavin DP, Kaplan MM: The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology 1996, 110: 271\u2013274.","journal-title":"Gastroenterology"},{"key":"35_CR40","first-page":"630","volume":"91","author":"J Rebollo Bernardez","year":"1999","unstructured":"Rebollo Bernardez J, Cifuentes Mimoso C, Pinar Moreno A, et al.: Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis. Rev Esp Enferm Dig 1999, 91: 630\u2013638.","journal-title":"Rev Esp Enferm Dig"},{"key":"35_CR41","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0168-8278(98)80128-1","volume":"29","author":"KW Burak","year":"1998","unstructured":"Burak KW, Urbanski SJ, Swain MG: Successful treatment of refractory type I autoimmune hepatitis with methotrexate. J Hepatol 1998, 29: 990\u2013993.","journal-title":"J Hepatol"},{"key":"35_CR42","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1111\/j.1572-0241.2001.05346.x","volume":"96","author":"A Venkataramani","year":"2001","unstructured":"Venkataramani A, Jones MB, Sorrell MF: Methotrexate therapy for refractory chronic active autoimmune hepatitis. Am J Gastro 2001, 96: 3432\u20133433.","journal-title":"Am J Gastro"},{"key":"35_CR43","first-page":"571","volume":"35","author":"S Kanzler","year":"1997","unstructured":"Kanzler S, Gerken G, Dienes HP, et al.: Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis-report of three cases. Z Gastroenterol 1997, 35: 571\u2013578.","journal-title":"Z Gastroenterol"},{"key":"35_CR44","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","volume":"5","author":"N Kerkar","year":"2005","unstructured":"Kerkar N, Dugan C, Rumbo C, et al.: Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transplantation 2005, 5: 1085\u20131089.","journal-title":"Am J Transplantation"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-005-0035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-005-0035-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-005-0035-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:49:59Z","timestamp":1587577799000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-005-0035-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1007\/s11938-005-0035-7","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}